These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 23321458

  • 21. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [Abstract] [Full Text] [Related]

  • 22. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [Abstract] [Full Text] [Related]

  • 23. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
    Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P, Schmitz C, Bartenstein P, Rominger A, Kipp M.
    Cells; 2019 Jan 28; 8(2):. PubMed ID: 30696113
    [Abstract] [Full Text] [Related]

  • 24. GFAP mRNA fluctuates in synchrony with chronic relapsing EAE symptoms in SJL/J mice.
    Kothavale A, Di Gregorio D, Somera FP, Smith ME.
    Glia; 1995 Jul 28; 14(3):216-24. PubMed ID: 7591033
    [Abstract] [Full Text] [Related]

  • 25. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS.
    J Neuroimmunol; 2008 Oct 15; 203(1):79-93. PubMed ID: 18687476
    [Abstract] [Full Text] [Related]

  • 26. TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.
    Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL.
    Eur J Nucl Med Mol Imaging; 2018 Jul 15; 45(8):1423-1431. PubMed ID: 29523925
    [Abstract] [Full Text] [Related]

  • 27. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation.
    Tsunoda I, Kuang LQ, Igenge IZ, Fujinami RS.
    J Neuroimmunol; 2005 Mar 15; 160(1-2):122-34. PubMed ID: 15710465
    [Abstract] [Full Text] [Related]

  • 28. [18F]CB251 PET/MR imaging probe targeting translocator protein (TSPO) independent of its Polymorphism in a Neuroinflammation Model.
    Kim K, Kim H, Bae SH, Lee SY, Kim YH, Na J, Lee CH, Lee MS, Ko GB, Kim KY, Lee SH, Song IH, Cheon GJ, Kang KW, Kim SE, Chung JK, Kim EE, Paek SH, Lee JS, Lee BC, Youn H.
    Theranostics; 2020 Mar 15; 10(20):9315-9331. PubMed ID: 32802194
    [Abstract] [Full Text] [Related]

  • 29. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
    Glabinski AR, Bielecki B, Kawczak JA, Tuohy VK, Selmaj K, Ransohoff RM.
    Autoimmunity; 2004 Mar 15; 37(6-7):465-71. PubMed ID: 15621573
    [Abstract] [Full Text] [Related]

  • 30. The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis.
    Batoulis H, Uhl M, Addicks K, Lehmann PV, Kuerten S.
    Glia; 2012 May 15; 60(5):794-805. PubMed ID: 22319015
    [Abstract] [Full Text] [Related]

  • 31. Delayed, relapsing experimental allergic encephalomyelitis in mice.
    Lublin FD, Maurer PH, Berry RG, Tippett D.
    J Immunol; 1981 Mar 15; 126(3):819-22. PubMed ID: 7462632
    [Abstract] [Full Text] [Related]

  • 32. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N, Mendel I, Ben-Nun A.
    Eur J Immunol; 1995 Apr 15; 25(4):985-93. PubMed ID: 7737302
    [Abstract] [Full Text] [Related]

  • 33. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.
    Magliozzi R, Columba-Cabezas S, Serafini B, Aloisi F.
    J Neuroimmunol; 2004 Mar 15; 148(1-2):11-23. PubMed ID: 14975582
    [Abstract] [Full Text] [Related]

  • 34. Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis.
    Amhaoul H, Hamaide J, Bertoglio D, Reichel SN, Verhaeghe J, Geerts E, Van Dam D, De Deyn PP, Kumar-Singh S, Katsifis A, Van Der Linden A, Staelens S, Dedeurwaerdere S.
    Neurobiol Dis; 2015 Oct 15; 82():526-539. PubMed ID: 26388398
    [Abstract] [Full Text] [Related]

  • 35. Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity.
    Berard JL, Kerr BJ, Johnson HM, David S.
    Glia; 2010 Nov 15; 58(15):1816-26. PubMed ID: 20645407
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis.
    Mattner F, Katsifis A, Staykova M, Ballantyne P, Willenborg DO.
    Eur J Nucl Med Mol Imaging; 2005 May 15; 32(5):557-63. PubMed ID: 15875181
    [Abstract] [Full Text] [Related]

  • 37. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
    Toft-Hansen H, Babcock AA, Millward JM, Owens T.
    J Neuroinflammation; 2007 Sep 20; 4():24. PubMed ID: 17883829
    [Abstract] [Full Text] [Related]

  • 38. Adhesion-related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis.
    Cannella B, Cross AH, Raine CS.
    Lab Invest; 1991 Jul 20; 65(1):23-31. PubMed ID: 1677055
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
    Aharoni R, Sasson E, Blumenfeld-Katzir T, Eilam R, Sela M, Assaf Y, Arnon R.
    Exp Neurol; 2013 Feb 20; 240():130-44. PubMed ID: 23153580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.